Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “THROMBOTIC MICROANGIOPATHY”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Early research (Phase 1)Study completedNCT01437384
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Eisai Inc. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing

Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 173
Not applicableStudy completedNCT04749810
What this trial is testing

Observational Study of Elizaria® in aHUS Patients

Who this might be right for
Atypical Hemolytic Uremic SyndromeaHUS
AO GENERIUM 50
Large-scale testing (Phase 3)Study completedNCT01438840
What this trial is testing

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Who this might be right for
Chronic ThrombocytopeniaImmune Thrombocytopenia
Eisai Inc. 49
Large-scale testing (Phase 3)Study completedNCT05566990
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
SK Plasma Co., Ltd. 34
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Not applicableLooking for participantsNCT07513948
What this trial is testing

Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40
Post-approval studies (Phase 4)UnknownNCT05135442
What this trial is testing

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03518203
What this trial is testing

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome
Children's Hospital Medical Center, Cincinnati 23
Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Large-scale testing (Phase 3)Study completedNCT01444417
What this trial is testing

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+3 more
Amgen 62
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Not applicableAvailableNCT02355782
What this trial is testing

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathy
Michal Nowicki
Not applicableUnknownNCT06466824
What this trial is testing

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Who this might be right for
Primary Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Not applicableStudy completedNCT05095896
What this trial is testing

The Serum Lipid Profiles in ITP: a Retrospective Study

Who this might be right for
Immune Thrombocytopenia
Ming Hou 457
Not applicableLooking for participantsNCT04005638
What this trial is testing

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaAutoimmune Neutropenia
University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Looking for participantsNCT05214391
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableUnknownNCT05835050
What this trial is testing

Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital

Who this might be right for
Immune Thrombocytopenic Purpura
Sohag University 50
Not applicableStudy completedNCT01770951
What this trial is testing

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome (aHUS)
Alexion Pharmaceuticals, Inc. 30
Next Page